COMP <GO>
CVNA vs PG // FORWARD P/E MULTIPLE
Carvana Co. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CVNA 3
— PG 12
▲ FORWARD P/E MULTIPLE LEADER: PG
LAST: $68.29 (-0.03%) • MKT CAP: $75.36B
forward-pe
45.0x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
forward-pe
21.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVNA VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CVNA | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.60% | 51.20% | -30.60 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.60% | 25.40% | -0.80 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 38.8x | 16.2x | +22.60 | PG | /valuation <GO> |
| Free Cash Flow Yield | 1.18% | 3.77% | -2.59 | PG | /fcf-yield <GO> |
| Operating Margin | 9.30% | 24.30% | -15.00 | PG | /operating-margins <GO> |
| Net Profit Margin | 6.90% | 19.00% | -12.10 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 48.60% | 0.30% | +48.30 | CVNA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.49 | 5.59 | +1.90 | CVNA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.50% | +0.50 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.6 | 62.7 | -0.05 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.87 | +0.17 | CVNA | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 45.0x | 21.7x | +23.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $75.36B | $372.21B | -$296.85B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CVNA REV | PG REV | CVNA GROSS % | PG GROSS % | CVNA FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.32B | $84.28B | 20.6% | 51.2% | $889.0M | $14.04B |
| FY 2024 | $13.67B | $84.04B | 21.0% | 51.4% | $827.0M | $16.52B |
| FY 2023 | $10.77B | $82.01B | 44.0% | 44.0% | $318.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVNA // BETA 1.04
PG // BETA 0.87